Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Carcinoma × Tumor-Agnostic × Clear all

Phase

Phase 1 36 Phase 2 24 Phase NA 13 Phase 3 10 Phase 1/2 3 Phase EARLY_PHASE1 2 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4 Gastrointestinal 2 Dermatologic 2 Breast 2 Tumor-Agnostic 1 NET 1 Endocrine 1 CNS 1

Conditions

Neoplasms 49 Neoplasm Metastasis 9 Adenocarcinoma 3 Neoplasms, Second Primary 2 Carcinoma, Squamous Cell 1 Carcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04362072 2025-06-11

Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer

Pfizer

Phase 4 Completed

71 enrolled 26 charts

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡